The Redox Biology of Schistosome Parasites and Applications for Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|24|3595-3611

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.24, 2012-08, pp. : 3595-3611

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Schistosome Histone Modifying Enzymes for Drug Development

By  

Current Pharmaceutical Design, Vol. 18, Iss. 24, 2012-08 ,pp. : 3567-3578

Bentham Science Publishers

Access to resources Recommend Favorite

Current Progress in the Development and Use of Artemether for Chemoprophylaxis of Major Human Schistosome Parasites

By  

Current Medicinal Chemistry, Vol. 8, Iss. 15, 2001-12 ,pp. : 1841-1859

Bentham Science Publishers

Access to resources Recommend Favorite

Selection of Targets for Drug Development Against Protozoan Parasites

By  

Current Drug Targets, Vol. 10, Iss. 3, 2009-03 ,pp. : 193-201

Bentham Science Publishers

Access to resources Recommend Favorite

The Plant-Type Ferredoxin-NADP+ Reductase/Ferredoxin Redox System as a Possible Drug Target Against Apicomplexan Human Parasites

By  

Current Pharmaceutical Design, Vol. 11, Iss. 24, 2005-09 ,pp. : 3159-3172

Bentham Science Publishers

Access to resources Recommend Favorite

Applications of Metabolomics in Drug Discovery and Development

By Wishart David S.  

Drugs in R&D, Vol. 9, Iss. 5, 2008-01 ,pp. : 307-322

Adis International

Access to resources Recommend Favorite